InvestSMART

4DMedical Limited (ASX:4DX)

ALERT: Price-sensitive ASX Announcement for 4DX
Current share price for 4DX : $3.990 0.57 (16.67%)+
Announcement
Release
29 May 2026 10:03AM
Price at Release
$3.420
Full Release
download
Summary
4DMedical Limited has entered a commercial agreement with SimonMed Imaging, a leading outpatient medical imaging provider in the United States, to deploy its CT:VQ™ and LDAf™ solutions across SimonMed's extensive network of over 170 imaging centers. This collaboration marks a significant commercial win for 4DMedical, facilitating immediate clinical deployment and supporting enhanced pulmonary assessment. The three-year agreement underlines confidence in 4DMedical's technology, with a pricing model based on per-scan rates and aims to develop reimbursement evidence, providing a strategic long-term opportunity despite not being immediately financially material.
Key Points
  • 4DMedical secures a commercial contract for CT:VQ™ with SimonMed Imaging.
  • SimonMed operates more than 170 outpatient imaging centers across the U.S.
  • Immediate clinical deployment of CT:VQ™ and LDAf™ on commercial terms reflects growing confidence in the technology.
  • The agreement is for three years with pricing based on per-scan rates.
  • The partnership will support the development of reimbursement evidence for CT:VQ™.
  • 4DMedical’s solutions enhance clinical decision-making for pulmonary assessment.
  • The agreement is not immediately financially material, but represents a long-term opportunity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.